SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-013445
Filing Date
2023-04-27
Accepted
2023-04-27 12:43:37
Documents
20
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A definitiveproxywithcard.htm DEF 14A 748670
2 board_recxpropsalfive.jpg GRAPHIC 117570
3 board_recxpropsalfour.jpg GRAPHIC 116906
4 chart-1e0d397d13de44b2aea.jpg GRAPHIC 13600
5 chart-4a7a535b97924095817.jpg GRAPHIC 115774
6 chart-6a37f88681a64d9a8fe.jpg GRAPHIC 105084
7 chart-aedb6718965f4da3987.jpg GRAPHIC 15947
8 chart-d45ded2a5358496890a.jpg GRAPHIC 16694
9 finalproxycard001.jpg GRAPHIC 161230
10 finalproxycard002.jpg GRAPHIC 140769
11 neoleukin_icon-01.jpg GRAPHIC 606581
12 neoleukin_icon-02.jpg GRAPHIC 587795
13 neoleukin_icon-03.jpg GRAPHIC 597543
14 neoleukin_icon-04.jpg GRAPHIC 578400
15 neoleukin_logo.jpg GRAPHIC 43055
16 recommendation-01.jpg GRAPHIC 53195
17 recommendation-02.jpg GRAPHIC 52869
18 recommendation-03.jpg GRAPHIC 52390
19 signature.jpg GRAPHIC 6207
20 signature_1.jpg GRAPHIC 8183
  Complete submission text file 0001628280-23-013445.txt   5400931
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 23853947
SIC: 2834 Pharmaceutical Preparations